A New Era in Microsurgery: Microsure’s MUSA 3 Prepares to Enter the European Market

Share

Robotization is occupying an increasingly important place in the field of medical technology, but when it comes to microsurgery and supermicrosurgery, precision standards are even higher. The Dutch company Microsure, one of the pioneers in this field, has developed a next-generation microsurgical robotic system called MUSA 3. This technology was specifically designed to help highly skilled surgeons achieve maximum precision during the most complex and small-scale operations.

In parallel with technological progress, the company is actively working on compliance with European regulations. Receiving the CE mark (European Conformity Certificate) for MUSA 3 is a crucial step that opens the way for this innovative platform into leading European clinics and hospitals.

MUSA 3 consists of two main components: the surgeon’s console and the mobile cart with robotic arms. The surgeon performs the operation while sitting in an ergonomic position, looking at a digital or hybrid microscope screen. Using specialized joysticks, the surgeon’s movements are transmitted to the robotic arms in real-time. The system automatically filters out the natural tremor of the human hand and scales the movements, allowing the surgeon to operate with unprecedented precision, even at the microscopic level.

One of the greatest advantages of this system is its exceptional flexibility. MUSA 3 allows doctors to work on difficult-to-access and vertically oriented wound planes without the need to rest their hands on a supportive surface to maintain stability. Furthermore, thanks to unique disposable adapters, the robot is compatible with the surgeons’ own trusted micro-instruments, significantly increasing the system’s functionality and its adaptability to various medical brands.

It is worth noting that Microsure’s previous model, MUSA 2, became the world’s first CE-certified microsurgical robot back in 2019. It successfully passed numerous clinical studies, including the treatment of breast cancer-related lymphedema. The clinical experience and feedback from surgeons gained during the practical use of MUSA 2 laid the foundation for the creation of MUSA 3, which fully addresses the real challenges of modern medicine. Upon completion of the ongoing local regulatory procedures, this robot will be ready to establish new standards in surgical practice.

microsure

theroboticsmedia

Share

spot_img

Other news